07 Nov
|
PRINCESS MARGARET CANCER CENTRE
|
Winnipeg
07 Nov
PRINCESS MARGARET CANCER CENTRE
Winnipeg
Clinical Research Coordinator III (Phase 1)Full-timeDepartment: ResearchCompensation: CAD 84,779 - CAD 105,968 per yearSite: Princess Margaret Cancer CentreReports to: Clinical Research Nurse ManagerHours: 37.5 per weekShifts: Monday-FridayStatus: Permanent Full-timeClosing Date: August 2, 2026Position Summary: The Clinical Research Coordinator collaborates with investigators and the health care team to assume responsibility for the overall patient management and coordination of several clinical studies for the Drug Development Program at Princess Margaret Cancer Centre. The research nurse will work primarily in the Phase 1 clinical trials group. Studies include pharma‑sponsored, cooperative group‑sponsored (such as NCIC) as well as Investigator‑initiated trials.DutiesRecruitment of study participants – identify and screen potential subjects, obtain informed consent.Coordination of patient visit schedules as per study protocol; execution of all aspects of study visits (assessment of adverse events, monitoring safety, medication, questionnaires, sample collection, including processing and shipment of samples according to clinical protocol, assessments, vital signs, ECG’s, monitoring and administration of treatments as per study protocol).Provides clinical care for patients participating in clinical trials and the implementation and coordination of all aspects of data collection and source documentation, as per UHN policy and ICH/GCP guidelines.QualificationsBachelor’s degree, or recognized equivalent, and current certificate of competence (licensure/registration) from a college legislated under the Regulated Health Professions Act.At minimum 3 to 5 years clinical and/or professional experience is required.Current registration with the College of Nurses of Ontario.Recognized certification in clinical research (ACRP or SOCRA) obtained or plans to work towards.Registered Nurse with a minimum of 3 (three)
years experience.Strong knowledge base in Phase I Clinical Trials.Chemotherapy certification (deSouza Institute) is preferred.Demonstrated knowledge and ability to utilize the nursing process in planning, implementing and evaluating patient care.Evidence of positive physical assessment, psychosocial assessment and patient/family teaching skill.Training in ICH/GCP guidelines is an asset.Knowledge of IATA shipping regulations and basic laboratory procedures is an asset.Excellent organizational and time management skills required.Strong analytical and problem‑solving skills.Excellent interpersonal, verbal and written communication skills required.Ability to set priorities and work independently with accuracy in a dynamic environment.Proficiency with MS Office software – Word, Excel and PowerPoint is preferred.Attention to detail and meticulous documentation practice.Autonomous clinical critical thinking ability.BenefitsCompetitive offer packages.Government organization and a member of the Healthcare of Ontario Pension Plan (HOOPP https://hoopp.Com/).Close access to transit and UHN shuttle service.A flexible work environment.Opportunities for development and promotions within a large organization.Additional perks (multiple corporate discounts including travel, restaurants, parking, phone plans, auto insurance discounts, on-site gyms, etc.).All applications must be submitted before the posting close date.Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue consideration of their application.Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.#J-18808-Ljbffr
📌 Clinical Research Coordinator Iii (Phase 1) - C$84,779 - C$105,968 A Year (Winnipeg)
🏢 PRINCESS MARGARET CANCER CENTRE
📍 Winnipeg